Metafold Therapeutics Inc is categorized under Research and Development Laboratories in San Francisco, CA and active since 2008.
Metafold Therapeutics Inc was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Bradley J Backes at the company’s single location by writing to 409 Illinois St, San Francisco, California CA 94158 or by phoning (415) 730-5431. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Metafold Therapeutics Inc |
| Contact Person: | Bradley J Backes |
| Address: | 409 Illinois St, San Francisco, California 94158 |
| Phone Number: | (415) 730-5431 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Metafold Therapeutics Inc was started in 2008 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Bradley J Backes for inquiries that concern Metafold Therapeutics Inc by calling the company number (415) 730-5431, as your correspondence is most welcome. Additionally, the physical location of the single location of Metafold Therapeutics Inc can be found at the coordinates 37.766695,-122.38797 as well as the street address 409 Illinois St in San Francisco, California 94158.
For its online presence, you may visit Metafold Therapeutics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.